Anshul Life Sciences 
Dealstreet

SAM, AZB act on acquisition of Anshul Life Sciences by Barentz

Dutch company Barentz has acquired Anshul Life Sciences.

Bar & Bench

Barentz has made an acquisition of Anshul Life Sciences for an undisclosed amount.

Shardul Amarchand Mangaldas & Co advised Barentz on this acquisition deal.

The transaction team consisted of by Roopal Kulsrestha (Partner), Neelam Pathak (Partner), Meghna Nachappa (Partner), Aparna R (Associate), Sandra Anil Varkey (Associate), Pranav Bajaj (Associate) and Sidharth Chamarthy (Associate).

Roopal Kulsrestha, Neelam Pathak

AZB & Partners advised Anshul Life Sciences and its promoters on this transaction.

The deal team comprised Senior Partner Vaidhyanadhan Iyer, Partner Sneha Nagvekar, Associates Deepti Narayanan, Priyasha Goyal, Jay Singhee and Meghna Somani.

Barentz is a leading global specialty ingredients solutions provider. With this acquisition, Barentz establishes a leading life science distribution platform in India and reinforces its commitment to providing innovative solutions and technical expertise pan-India.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi High Court urges BCI and BCD to frame policy to provide financial assistance to kin of deceased lawyers

WhatsApp abused dominant position by imposing privacy policy on “take it or leave it” basis: CCI to NCLAT

Supreme Court rejects plea seeking age relaxation in Central government jobs for displaced Kashmiri Pandits

Buying air tickets not a commercial transaction to attract Commercial Courts Act: Delhi High Court

Supreme Court upholds lawyer's suspension for making scandalous allegations against woman; slaps ₹1 lakh costs

SCROLL FOR NEXT